首页> 外文期刊>Nature clinical practice. Cardiovascular medicine >Launching a clinical program of stem cell therapy for cardiovascular repair.
【24h】

Launching a clinical program of stem cell therapy for cardiovascular repair.

机译:启动干细胞治疗心血管修复的临床计划。

获取原文
获取原文并翻译 | 示例
           

摘要

Since the feasibility of stem cell therapy has been recognized, enthusiasm for this therapy has grown exponentially. Nevertheless, as professionals we must realize that this enthusiasm should relate not only to our scientific interest but also to the care of our patients. Within the next decade, patients' demand for the latest therapies is likely to rise because of changes in health care systems that will broaden availability. Stem cell therapy is likely to be among these in-demand treatments, and we must be prepared for this change. In this Review we discuss the basic principles of how to launch a clinical program for stem cell therapy for cardiovascular repair. First, we look at the composition of the program team. Second, we describe the different types of stem cells available in clinical practice. Third, we present in depth the two most widely applicable delivery approaches. Finally, we discuss selection of patients and approaches and clinical and imaging methods by which to evaluate the safety andefficacy of this therapy.
机译:由于已经认识到干细胞疗法的可行性,因此对该疗法的热情呈指数增长。但是,作为专业人员,我们必须意识到,这种热情不仅与我们的科学兴趣有关,而且与患者的护理有关。在未来十年内,由于医疗保健系统的变化将扩大可用性,患者对最新疗法的需求可能会上升。这些需求疗法可能包括干细胞疗法,因此我们必须为这种变化做好准备。在这篇综述中,我们讨论了如何启动用于心血管修复的干细胞治疗临床计划的基本原理。首先,我们看一下程序团队的组成。其次,我们描述了临床实践中可用的不同类型的干细胞。第三,我们深入介绍两种最广泛应用的交付方式。最后,我们讨论了选择患者和方法以及临床和影像学方法,以评估该疗法的安全性和有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号